Tomsche David Scott

SEC Form 4 insider trading activity

Tomsche David Scott has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 28, 2025.

On the most recent filing, Tomsche David Scott is listed as Director at IMMUCELL CORP. Inside the rolling window, Tomsche David Scott reported 1 open-market purchase totaling $16K in ICCC and no open-market sales.

Companies traded

Other insiders at ICCC

Insider Buying

$16K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ICCCPurchase$16KNov 28SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Tomsche David Scott made?

Tomsche David Scott has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2025.

Which companies does Tomsche David Scott trade?

Tomsche David Scott has filed SEC Form 4 disclosures for 1 company, including ICCC.

When was Tomsche David Scott's most recent SEC Form 4 filing?

Tomsche David Scott's most recent SEC Form 4 filing on Tracefour is dated Nov 28, 2025.

What is Tomsche David Scott's total buy and sell value in the current window?

Inside the rolling retention window, Tomsche David Scott bought $16K and sold $0 based on SEC Form 4 filings.

What was Tomsche David Scott's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 3,266 ICCC shares on 2025-11-25, worth $16K, per SEC Form 4 filings.